I

n the wake of the controversy over EpiPen pricing, lawmakers in several states are introducing bills that would allow pharmacists to substitute alternatives for the pricey allergic-reaction device without requiring a new prescription from a physician.

The latest example was introduced last week in Ohio, where pharmacists are currently prohibited from making any substitutions for the device. Similar legislation was introduced in recent weeks in New York and Vermont, and last fall in New Jersey. A somewhat comparable was also introduced in Hawaii.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy